AnalystsMayank MamtaniMayank Mamtani's Stock Forecasts
AnalystsMayank Mamtani
Sectors:
Industries:
Analyst Ranking
Top 1%
#27 out of 4046 analysts
Average Return
+49.01%
Win Rate
48%25 out of 52
Risk vs Reward
Poor
Good
Mayank Mamtani's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Novavax IncNVAX | +1,295.56% | $13.05 | $182.12 | 2020-03-27 - 2021-03-26 | Strong Buy |
Novavax IncNVAX | +946.95% | $19.83 | $207.61 | 2020-04-24 - 2021-04-23 | Strong Buy |
Fortress Biotech IncFBIO | +221.05% | $1.33 | $4.27 | 2020-03-13 - 2021-03-12 | Strong Buy |
Arrowhead Pharmaceuticals IncARWR | +176.37% | $26.32 | $72.74 | 2020-03-13 - 2021-03-12 | Strong Buy |
Novavax IncNVAX | +149.90% | $83.61 | $208.94 | 2020-06-29 - 2021-06-29 | Strong Buy |
Mayank Mamtani's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Intercept Pharmaceuticals IncICPT | 4 | Strong Buy | $28.00 | +100.72% | Maintains | a month ago |
Gain Therapeutics IncGANX | 3 | Hold | $5.00 | +53.37% | Downgrades | a month ago |
Altimmune IncALT | 2 | Strong Buy | $26.00 | +103.60% | Maintains | 2 months ago |
Cassava Sciences IncSAVA | 3 | Strong Buy | $44.00 | +5.21% | Maintains | 2 months ago |
Fortress Biotech IncFBIO | 3 | Strong Buy | $6.00 | +597.67% | Maintains | 3 months ago |
Madrigal Pharmaceuticals IncMDGL | 1 | Hold | $75.00 | +15.40% | Downgrades | 3 months ago |
Lineage Cell Therapeutics IncLCTX | 1 | Strong Buy | $4.00 | +253.98% | Initiates Coverage On | 4 months ago |
Tg Therapeutics IncTGTX | 4 | Strong Buy | $17.00 | +187.16% | Maintains | 4 months ago |
Inmune Bio IncINMB | 2 | Hold | $7.00 | +12.90% | Downgrades | 4 months ago |
Vaxart IncVXRT | 2 | Hold | $6.00 | +175.23% | Maintains | 4 months ago |
X4 Pharmaceuticals IncXFOR | 2 | Strong Buy | $7.00 | +309.36% | Maintains | 4 months ago |
Cymabay Therapeutics IncCBAY | 2 | Strong Buy | $8.00 | +128.57% | Maintains | 4 months ago |
Novavax IncNVAX | 7 | Strong Buy | $203.00 | +1,015.38% | Maintains | 5 months ago |
Tff Pharmaceuticals IncTFFP | 1 | Strong Buy | $18.00 | +343.35% | Maintains | 6 months ago |
Frequency Therapeutics IncFREQ | 1 | Strong Buy | $10.00 | +458.66% | Maintains | 6 months ago |
Allena Pharmaceuticals IncALNAQ | 3 | Hold | $0.50 | +566.67% | Downgrades | 6 months ago |
Spectrum Pharmaceuticals IncSPPI | 3 | Strong Buy | $4.00 | +830.23% | Maintains | 6 months ago |
Nighthawk Biosciences IncNHWK | 1 | Strong Buy | $8.00 | +362.43% | Maintains | 6 months ago |
Seelos Therapeutics IncSEEL | 2 | Strong Buy | $4.00 | +288.35% | Maintains | 7 months ago |
Mustang Bio IncMBIO | 1 | Strong Buy | $6.00 | +1,179.32% | Maintains | 8 months ago |
Biovie IncBIVI | 1 | Strong Buy | $27.00 | +984.34% | Maintains | 10 months ago |
Checkpoint Therapeutics IncCKPT | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | a year ago |
Eloxx Pharmaceuticals IncELOX | 1 | Strong Buy | $5.00 | N/A | Initiates Coverage On | a year ago |
Arrowhead Pharmaceuticals IncARWR | 2 | Strong Buy | $106.00 | N/A | Maintains | 2 years ago |
Arcturus Therapeutics Holdings IncARCT | 2 | Hold | $77.00 | N/A | Downgrades | 2 years ago |
Acasti Pharma IncACST | 1 | Strong Buy | $2.00 | N/A | Upgrades | 2 years ago |
Galmed Pharmaceuticals LtdGLMD | 2 | Hold | $8.00 | N/A | Downgrades | 2 years ago |
Galectin Therapeutics IncGALT | 1 | Strong Buy | $4.00 | N/A | Maintains | 2 years ago |
Imv IncIMV | 1 | Hold | $3.00 | N/A | Downgrades | 3 years ago |
Liberty Media CorpFWONK | 1 | Strong Buy | $39.00 | N/A | Maintains | 3 years ago |
Medicinova IncMNOV | 1 | Strong Buy | $11.00 | N/A | Maintains | 3 years ago |
Genfit SaGNFT | 1 | Strong Buy | $34.00 | N/A | Maintains | 3 years ago |
Ngm Biopharmaceuticals IncNGM | 1 | Strong Buy | $30.00 | N/A | Maintains | 3 years ago |
Arqule IncARQL | 1 | Hold | $20.00 | N/A | Downgrades | 3 years ago |
©2022 WallStreetZen
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.